ATC
EW icon

Argent Trust Co’s Edwards Lifesciences EW Stock Holding History

Argent Trust Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Buy
+2,267
New +$190K 0.01% 752
2025
Q1 		– Sell
-2,816
Closed -$208K – 715
2024
Q4 		$208K Buy
+2,816
New +$197K 0.01% 658
2024
Q3 		– Sell
-3,522
Closed -$325K – 719
2024
Q2 		$325K Buy
3,522
+21
+0.6% +$1.86K 0.01% 507
2024
Q1 		$335K Buy
3,501
+50
+1% +$4.2K 0.02% 493
2023
Q4 		$263K Sell
3,451
-429
-11% -$29.9K 0.01% 531
2023
Q3 		$269K Sell
3,880
-289
-7% -$23.2K 0.01% 513
2023
Q2 		$393K Buy
4,169
+790
+23% +$68.7K 0.02% 438
2023
Q1 		$280K Buy
3,379
+48
+1% +$3.77K 0.02% 438
2022
Q4 		$249K Sell
3,331
-204
-6% -$15.7K 0.02% 458
2022
Q3 		$291K Sell
3,535
-1,812
-34% -$174K 0.02% 426
2022
Q2 		$509K Sell
5,347
-58
-1% -$6K 0.03% 338
2022
Q1 		$636K Sell
5,405
-239
-4% -$26.8K 0.04% 318
2021
Q4 		$731K Hold
5,644
– – 0.04% 300
2021
Q3 		$639K Buy
5,644
+132
+2% +$15.1K 0.04% 307
2021
Q2 		$570K Sell
5,512
-388
-7% -$36.6K 0.04% 318
2021
Q1 		$494K Sell
5,900
-60
-1% -$5.07K 0.03% 328
2020
Q4 		$543K Sell
5,960
-455
-7% -$37.7K 0.04% 302
2020
Q3 		$512K Buy
6,415
+1,957
+44% +$153K 0.05% 290
2020
Q2 		$308K Buy
4,458
+255
+6% +$18.1K 0.03% 357
2020
Q1 		$264K Sell
4,203
-126
-3% -$9.09K 0.03% 349
2019
Q4 		$336K Sell
4,329
-480
-10% -$37.5K 0.03% 363
2019
Q3 		$353K Sell
4,809
-1,455
-23% -$102K 0.03% 349
2019
Q2 		$386K Sell
6,264
-60
-0.9% -$3.63K 0.04% 327
2019
Q1 		$403K Buy
6,324
+249
+4% +$14.2K 0.04% 313
2018
Q4 		$310K Buy
6,075
+2,106
+53% +$107K 0.04% 340
2018
Q3 		$227K Sell
3,969
-1,452
-27% -$71K 0.03% 393
2018
Q2 		$262K Buy
+5,421
New +$253K 0.03% 373

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Argent Trust Co's EW Position: Q2 2026 in Review

Argent Trust Co opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,267 shares worth $205K. The stake represents 0.01% of the portfolio and ranks #752 among its holdings. This is a return to the name: Argent Trust Co previously reported a position in EW as recently as Q4 2024.

Argent Trust Co first reported a position in EW in Q2 2018 and has held it in 27 quarters since. The position peaked at $731K in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Argent Trust Co held 2,267 shares of Edwards Lifesciences worth $205K as of Q2 2026.
  • Edwards Lifesciences was a new Argent Trust Co position in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Argent Trust Co's portfolio in Q2 2026, its #752 holding.
  • Argent Trust Co first reported a position in Edwards Lifesciences in Q2 2018 and has held it in 27 quarters since.
  • Argent Trust Co's Edwards Lifesciences position peaked at $731K in Q4 2021.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Argent Trust Co's 13F filing for Q2 2026, filed 6 Aug 2026.